...
机译:简短交流:Suberoylyllide异羟肟酸(SAHA),一种批准用于治疗皮肤T细胞淋巴瘤的HDAC抑制剂,激活潜在的HIV 1型基因表达
Department of Molecular Genetics, Microbiology and Immunology, UMDNJ-Robert Wood Johnson Medical School, Piscataway, New Jersey 08854.;
Department of Molecular Genetics, Microbiology and Immunology, UMDNJ-Robert Wood Johnson Medical School, Piscataway, New Jersey 08854.;
Department of Molecular Genetics, Microbiology and Immunology, UMDNJ-Robert Wood Johnson Medical School, Piscataway, New Jersey 08854.;
Department of Molecular Genetics, Microbiology and Immunology, UMDNJ-Robert Wood Johnson Medical School, Piscataway, New Jersey 08854.;
机译:简短交流:Suberoylyllide异羟肟酸(SAHA)激活了潜在的HIV 1型基因表达,SAHA是一种HDAC抑制剂,已批准用于治疗皮肤T细胞淋巴瘤。
机译:由强效HDAC抑制剂辛二酰苯胺异羟肟酸诱导的潜在HIV的表达。
机译:高效HDAC抑制剂Suberoylanilide异羟肟酸诱导的潜在HIV的表达
机译:通过有机烯化合物作为Zn〜(2+)结合基团的Zn〜(2+)结合基团的Zn〜(2+)结合基团的组织化合物作为宫颈癌的HOMO SAPIENS II HDAC抑制剂
机译:组蛋白脱乙酰基酶(HDAC)抑制剂的结构要求:在C3,C6和C7位置修饰的Suberoylanilide异羟肟酸(SAHA)类似物可提高选择性
机译:简短交流:Suberoylyllide异羟肟酸(SAHA)一种批准用于治疗皮肤T细胞淋巴瘤的HDAC抑制剂激活潜在的HIV 1型基因表达
机译:简短交流:Suberoylyllide异羟肟酸(SAHA),一种批准用于治疗皮肤T细胞淋巴瘤的HDAC抑制剂,激活潜在的HIV 1型基因表达